Shopping Cart
- Remove All
Your shopping cart is currently empty
Canvuparatide (MBX 2109) is a prodrug of a parathyroid hormone (PTH) peptide that releases a bioactive PTH[1-32] agonist peptide. This peptide retains a C-terminal fatty acylated lysine (Lys33), which extends the half-life of Canvuparatide. It is utilized in the study of hypoparathyroidism symptoms such as hypocalcemia and hyperphosphatemia.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder |
| Description | Canvuparatide (MBX 2109) is a prodrug of a parathyroid hormone (PTH) peptide that releases a bioactive PTH[1-32] agonist peptide. This peptide retains a C-terminal fatty acylated lysine (Lys33), which extends the half-life of Canvuparatide. It is utilized in the study of hypoparathyroidism symptoms such as hypocalcemia and hyperphosphatemia. |
| Synonyms | MBX 2109, Canvuparatide |
| Molecular Weight | 5873.83 |
| Formula | C263H441N65O81S2 |
| Cas No. | 2925554-87-4 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.